These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 3499271

  • 1. Depletion of asialo-GM1+ cells from the F1 recipient mice prior to irradiation and transfusion of parental spleen cells prevents mortality to acute graft-versus-host disease and induction of anti-host specific cytotoxic T cells.
    Varkila K.
    Clin Exp Immunol; 1987 Sep; 69(3):652-9. PubMed ID: 3499271
    [Abstract] [Full Text] [Related]

  • 2. A subset of asialo GM1+ cells play a protective role in the occurrence of graft-versus-host disease in mice.
    De Ruysscher D, Sobis H, Vandeputte M, Waer M.
    J Immunol; 1991 Jun 15; 146(12):4065-70. PubMed ID: 1828259
    [Abstract] [Full Text] [Related]

  • 3. Reduction of acute graft-versus-host disease-related mortality and cytotoxic T lymphocyte induction after pretreatment of the recipient with anti-asialo GM1 antibody in the murine P-to-F1 model.
    Varkila K, Hurme M.
    Transplant Proc; 1987 Feb 15; 19(1 Pt 3):2690-1. PubMed ID: 3274580
    [No Abstract] [Full Text] [Related]

  • 4. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L, Baenziger J, Pircher H, Hengartner H, Zinkernagel RM.
    J Immunol; 1986 Jun 15; 136(12):4674-80. PubMed ID: 3486908
    [Abstract] [Full Text] [Related]

  • 5. Natural killer (NK) cells and graft-versus-host disease (GVHD): no correlation between the NK cell levels and GVHD in the murine P----F1 model.
    Varkila K, Hurme M.
    Immunology; 1985 Jan 15; 54(1):121-6. PubMed ID: 3972429
    [Abstract] [Full Text] [Related]

  • 6. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A, Nestel FP, Seemayer TA, Lapp WS.
    J Immunol; 1986 Dec 01; 137(11):3420-7. PubMed ID: 3537120
    [Abstract] [Full Text] [Related]

  • 7. Asialo-GM1-positive T killer cells are generated in F1 mice injected with parental spleen cells.
    Knobloch C, Dennert G.
    J Immunol; 1988 Feb 01; 140(3):744-9. PubMed ID: 2448375
    [Abstract] [Full Text] [Related]

  • 8. Prevention of lethal, minor-determinate graft-host disease in mice by the in vivo administration of anti-asialo GM1.
    Charley MR, Mikhael A, Bennett M, Gilliam JN, Sontheimer RD.
    J Immunol; 1983 Nov 01; 131(5):2101-3. PubMed ID: 6355291
    [Abstract] [Full Text] [Related]

  • 9. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R, Suzuki S, Ebina N, Kumagai K.
    J Immunol; 1985 Apr 01; 134(4):2139-48. PubMed ID: 2579129
    [Abstract] [Full Text] [Related]

  • 10. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
    Yoshioka T, Sato S, Fujiwara H, Hamaoka T.
    Jpn J Cancer Res; 1986 Aug 01; 77(8):825-32. PubMed ID: 3093429
    [Abstract] [Full Text] [Related]

  • 11. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E, Ishikawa H, Saito K.
    J Immunol; 1983 Sep 01; 131(3):1142-8. PubMed ID: 6604089
    [Abstract] [Full Text] [Related]

  • 12. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells.
    Thiele DL, Bryde SE, Lipsky PE.
    J Immunol; 1988 Nov 15; 141(10):3377-82. PubMed ID: 3053897
    [Abstract] [Full Text] [Related]

  • 13. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
    Thiele DL, Charley MR, Calomeni JA, Lipsky PE.
    J Immunol; 1987 Jan 01; 138(1):51-7. PubMed ID: 2946780
    [Abstract] [Full Text] [Related]

  • 14. Experimental studies of immunologically mediated enteropathy. II. Role of natural killer cells in the intestinal phase of murine graft-versus-host reaction.
    Mowat AM, Felstein MV.
    Immunology; 1987 Jun 01; 61(2):179-83. PubMed ID: 3596637
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A subpopulation of allospecific cytotoxic T-cell precursors with phenotypic characteristics of natural killer cells.
    Kaplan J, Wasserman K.
    Nat Immun Cell Growth Regul; 1985 Jun 01; 4(6):305-14. PubMed ID: 2418351
    [Abstract] [Full Text] [Related]

  • 20. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC, Tibbe GJ, Noort WA, Bril-Bazuin C, Benner R, Savelkoul HF.
    Bone Marrow Transplant; 1994 Mar 01; 13(3):293-301. PubMed ID: 8199571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.